KLRB1 and inflammatory bowel disease: We isolated T cells from the homogenized lamina propria lymphocytes (LPL) of IBD patients and controls and found that, in contrast to published data[20], neither CD161+ nor CD161- effector T cells from IBD patients were resistant to suppression by a standardized Treg population in vitro.